NEW YORK, April 10, 2014 /PRNewswire/ -- Brinson
Patrick Securities Corporation ("Brinson Patrick") announced
today that the firm has re-launched its equity research department
with the recent initiation of coverage on several life sciences
companies. The research effort is being spearheaded by Christopher
James, M.D., Managing Director and Senior Equity Research
Analyst.
Dr. James has launched coverage on the following pharmaceutical
companies, Corcept Therapeutics Incorporated (NASDAQ: CORT) and
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND); biotechnology
company, Opexa Therapeutics, Inc. (NASDAQ: OPXA) and;
biopharmaceutical companies, MannKind Corporation (NASDAQ: MNKD)
and Rexahn Pharmaceuticals, Inc. (NYSE MKT: RNN). To sign up
to be added to Brinson Patrick's research distribution list, please
click here: Research sign-up form.
"We are very pleased to announce the revitalization of Brinson
Patrick's research department," noted Todd Wyche, Chief Executive
Officer of Brinson Patrick and also the head of the Brinson Patrick
division of Meyers Associates. Dr. James, who trained in
neurological surgery at Cornell-New York Hospital and Memorial
Sloan Kettering Cancer Center, has brought a unique set of
scientific, medical, and clinical skills to his coverage of life
sciences companies at Brinson Patrick. Moreover, his in-house
experience as Chief Medical Officer and Senior Vice President of
Medical Affairs for Retrophin, Inc. (NASDAQ: RTRX), in addition to
his prior positions as Senior Equity Research Analyst at Rodman
& Renshaw and MLV & Co., and his tenure on the buy-side at
Trivium Capital Management and MSMB Capital Management, are a
tremendous asset as we continue to expand and grow the business.
During 2014, we plan to continue building out the life sciences
platform, with a focus on companies with strong growth potential
and novel agents in development for serious diseases including
cancer, infectious disease, neurological, inflammatory, metabolic,
and cardiovascular diseases.
"At the same time, we continue to expand our investment banking
arm through Brinson Patrick, a division of Meyers Associates,
LP. This division, created in September 2013 to leverage Meyers' strong retail
network and Brinson Patrick's corporate financing expertise, has
allowed clients to benefit from the synergies of our two
organizations. This includes Brinson Patrick's expertise of
employing the DOCS® (Dynamic Offering of Common Stock)
at-the-market (ATM) financing facility – giving corporate clients
flexible access to capital. We are experiencing robust ATM activity
at our firm and expect to see continued industry-wide demand for
ATMs throughout the balance of 2014," noted Wyche.
About Brinson Patrick
With expertise across numerous industries, and a focus on life
science and real-estate related businesses, Brinson Patrick
Securities Corporation provides equity research, as well as an
18-year track record of employing the low-profile and flexible
DOCS® (Dynamic Offering of Common Stock) ATM financing
facility for publicly traded companies. Additionally, through
"Brinson Patrick, a division of Meyers Associates, LP," clients can
tap into Meyers Associates' suite of investment banking services
and its growing network of over 10,000 retail accounts, including
high net worth investors.
About Meyers Associates, L.P.
Meyers Associates, L.P. is a full-service investment banking and
securities brokerage firm that focuses on building trusted
partnerships with its retail and corporate clients. Meyers' key
focus is on public offering, private placement, reverse mergers,
alternative structured financing, and merger and acquisition
advisory services geared primarily to emerging growth companies in
the healthcare, technology and digital media sectors. Meyers offers
its clients a wide range of investment strategies including
speculative, short, and long term trading ideas. Meyers also offers
the ability to purchase mutual funds and a variety of fixed income
products such as government, corporate, high yield, municipal and
money market instruments. For any questions regarding Meyers
Associates, L.P. please contact Bruce
Meyers at 212-742-4200.
Photo -
http://photos.prnewswire.com/prnh/20130429/NY02685LOGO
SOURCE Brinson Patrick Securities Corporation